Ignite Creation Date:
2024-05-06 @ 7:55 PM
Last Modification Date:
2024-10-26 @ 3:17 PM
Study NCT ID:
NCT06186648
Status:
RECRUITING
Last Update Posted:
2024-04-19
First Post:
2023-12-06
Brief Title:
Evaluation of Treatment by Glofitamab in Combination With Rituximab or Obinutuzumab Plus CHOP in Patients With RIchter Syndrome
Sponsor:
French Innovative Leukemia Organisation
Organization:
French Innovative Leukemia Organisation
Organization Data
Organization:
French Innovative Leukemia Organisation
Class:
OTHER
Study ID:
FILOCLL015 - GLORIFY
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
French Innovative Leukemia Organisation
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Hoffmann-La Roche | INDUSTRY |